MXPA04012695A - Composiciones contra procesos inflamatorios. - Google Patents

Composiciones contra procesos inflamatorios.

Info

Publication number
MXPA04012695A
MXPA04012695A MXPA04012695A MXPA04012695A MXPA04012695A MX PA04012695 A MXPA04012695 A MX PA04012695A MX PA04012695 A MXPA04012695 A MX PA04012695A MX PA04012695 A MXPA04012695 A MX PA04012695A MX PA04012695 A MXPA04012695 A MX PA04012695A
Authority
MX
Mexico
Prior art keywords
inflammation
mammal
believed
risk
plant material
Prior art date
Application number
MXPA04012695A
Other languages
English (en)
Inventor
Martin Grigorov
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MXPA04012695A publication Critical patent/MXPA04012695A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A23K50/48—Moist feed
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A23K20/121—Heterocyclic compounds containing oxygen or sulfur as hetero atom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/174—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/20—Inorganic substances, e.g. oligoelements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K40/00—Shaping or working-up of animal feeding-stuffs
    • A23K40/25—Shaping or working-up of animal feeding-stuffs by extrusion
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A23K50/42—Dry feed
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/244—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from corms, tubers or roots, e.g. glucomannan
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
    • A23L7/10—Cereal-derived products
    • A23L7/117—Flakes or other shapes of ready-to-eat type; Semi-finished or partly-finished products therefor
    • A23L7/135—Individual or non-extruded flakes, granules or shapes having similar size, e.g. breakfast cereals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
    • A23L7/10—Cereal-derived products
    • A23L7/161—Puffed cereals, e.g. popcorn or puffed rice
    • A23L7/165—Preparation of puffed cereals involving preparation of meal or dough as an intermediate step
    • A23L7/17—Preparation of puffed cereals involving preparation of meal or dough as an intermediate step by extrusion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Nutrition Science (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medical Informatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Physiology (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Transplantation (AREA)

Abstract

Se proporcionan composiciones capaces de reducir un riesgo de inflamacion en un(os) mamifero(s). La composicion contiene una cantidad terapeuticamente efectiva de un material de planta procesado termicamente (p. ej., extrudido) que incluye (-metileno-(-butirolactona ((-MGBL) y/o varios fitoquimicos padres estructuralmente relacionados, capaces de inhibir la actividad enzimatica y/o transcripcional en el mamifero, lo que se cree que trata y/o previene la inflamacion. A este respecto, puede reducirse el riesgo de incidencia de otra enfermedad o de malestares que se cree que son causados por la inflamacion (p. ej., la inflamacion cronica). La fuente fitoquimica puede derivarse de un solo material de planta, tal como la achicoria.
MXPA04012695A 2002-06-26 2003-06-26 Composiciones contra procesos inflamatorios. MXPA04012695A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39173902P 2002-06-26 2002-06-26
PCT/EP2003/006718 WO2004002505A1 (en) 2002-06-26 2003-06-26 Compositions against inflammatory processes

Publications (1)

Publication Number Publication Date
MXPA04012695A true MXPA04012695A (es) 2005-12-14

Family

ID=30000746

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04012695A MXPA04012695A (es) 2002-06-26 2003-06-26 Composiciones contra procesos inflamatorios.

Country Status (13)

Country Link
US (1) US20040208944A1 (es)
EP (2) EP1969951B1 (es)
JP (1) JP4594086B2 (es)
CN (1) CN100574780C (es)
AU (1) AU2003280503B2 (es)
BR (1) BRPI0312035A2 (es)
CA (1) CA2488279C (es)
DE (1) DE60324924D1 (es)
ES (2) ES2532852T3 (es)
MX (1) MXPA04012695A (es)
RU (1) RU2312672C2 (es)
WO (1) WO2004002505A1 (es)
ZA (1) ZA200500741B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040001898A1 (en) * 2002-06-26 2004-01-01 Armand Malnoe Compositions and methods for detoxification and cancer prevention
WO2005102315A1 (en) 2004-04-23 2005-11-03 Magnachem International Laboratories, Inc. Synthetic lactone formulations for pain control
US20060216363A1 (en) * 2005-03-28 2006-09-28 Liu Su Y Novel herbal composition
CN101277708B (zh) * 2005-10-06 2013-02-13 雀巢技术公司 用于改良免疫性的益生肠道球菌
US7226623B2 (en) * 2005-10-31 2007-06-05 Rutgers, The State University Of New Jersey In vitro and in vivo anti-inflammatory effects of a sesquiterpene lactone extract from chicory (Cichorium intybus L.)
BRPI0709852A2 (pt) * 2006-03-29 2011-07-26 Nestec Sa suplementos dietÉticos contendo probiàticos
EP2054044B1 (de) * 2006-08-02 2014-07-23 Johannes Gutenberg-Universität Mainz Arzneimittel gegen lct-vergiftungen
JP2009143849A (ja) * 2007-12-14 2009-07-02 Noevir Co Ltd 抗老化剤、美白剤、抗酸化剤、抗炎症剤、及び保湿剤
US8501431B2 (en) * 2008-10-24 2013-08-06 Magnachem International Laboratories, Inc. Method for screening for compounds selectively interacting with RAD9
CN114272237A (zh) * 2022-01-21 2022-04-05 苏州大学附属第一医院 一种用于治疗骨性关节炎的银杏提取物

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4256774A (en) * 1977-07-11 1981-03-17 The Procter & Gamble Company Decaffeination process
US5004596A (en) * 1986-01-17 1991-04-02 Cocherell Francis E Anhydrous toothpaste or dental cream composition
US4752139A (en) * 1986-10-14 1988-06-21 Wenger Manufacturing, Inc. Preconditioning apparatus for extruder
US4781939A (en) * 1986-10-28 1988-11-01 Nestec, S.A. Layered meat emulsion product and method of producing same
DE3874613T2 (de) * 1987-06-05 1993-05-13 Mitsui Toatsu Chemicals Zusatz fuer viehfutter, zusatz enthaltendes viehfutter und verfahren zur herstellung eines zusatzes.
JPS63309147A (ja) 1987-06-09 1988-12-16 Nippon Beet Sugar Mfg Co Ltd 飼料添加物の製造方法
DE3933528C1 (es) * 1989-10-04 1990-12-06 Effem Gmbh, 2810 Verden, De
JPH11318387A (ja) * 1989-10-31 1999-11-24 Kanebo Ltd 抗炎症用食品
JP3411595B2 (ja) * 1991-09-26 2003-06-03 日本臓器製薬株式会社 フラノン誘導体を含有する医薬組成物
US5486049A (en) 1994-01-28 1996-01-23 Nestec S.A. Apparati for mixing fluid substances
CN1037315C (zh) * 1995-03-24 1998-02-11 秦国忠 咖啡健神饮料
US5952033A (en) * 1996-12-24 1999-09-14 Nestec S.A. Gelatinized cereal product containing oligosaccharide and processes of preparing and using same
US5905089A (en) * 1997-04-14 1999-05-18 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Use of sesquiterpene lactones for treatment of severe inflammatory disorders
GB9723059D0 (en) * 1997-10-31 1998-01-07 Mars Uk Ltd Pet food
US6200594B1 (en) * 1999-12-29 2001-03-13 Vital Dynamics, Inc. Breast-enhancing, herbal compositions and methods of using same
FR2806627B1 (fr) * 2000-03-22 2002-09-06 Medicaler Procede d'extraction par un solvant de composes actifs de la chicoree
EP1260212A1 (de) * 2001-05-21 2002-11-27 Cognis France S.A. Kosmetische Mittel
US20030157061A1 (en) * 2001-12-05 2003-08-21 Pharmacia Corporation Combinations of a cyclooxygenase-2 selective inhibitor and a TNFalpha antagonist and therapeutic uses therefor

Also Published As

Publication number Publication date
RU2312672C2 (ru) 2007-12-20
WO2004002505A1 (en) 2004-01-08
ES2532852T3 (es) 2015-04-01
JP2005535632A (ja) 2005-11-24
EP1969951B1 (en) 2015-01-28
EP1969951A2 (en) 2008-09-17
JP4594086B2 (ja) 2010-12-08
DE60324924D1 (es) 2009-01-08
AU2003280503A1 (en) 2004-01-19
CN100574780C (zh) 2009-12-30
EP1969951A3 (en) 2008-10-29
CN1662248A (zh) 2005-08-31
CA2488279C (en) 2010-11-09
CA2488279A1 (en) 2004-01-08
EP1515736A1 (en) 2005-03-23
US20040208944A1 (en) 2004-10-21
RU2005101763A (ru) 2005-07-10
AU2003280503B2 (en) 2009-02-05
BRPI0312035A2 (pt) 2016-06-21
EP1515736B1 (en) 2008-11-26
ES2316778T3 (es) 2009-04-16
ZA200500741B (en) 2006-03-29

Similar Documents

Publication Publication Date Title
WO2004046345A3 (en) Use of hmgb fragments as anti-inflammatory agents
NO20013241D0 (no) Celleadhesjonsinhiberende anti-inflammatoriske og immunundertrykkende forbindelser
MX342293B (es) Composiciones bioactivas de plantas de theacea y procesos para su produccion y uso.
UA99101C2 (ru) Композиция для местного ухода за кожей, содержащая соединения глицерина ди- и моносалицилата
DK2465493T3 (da) Topiske sammensætninger til forebyggelsen og behandlingen af irritation af mukøse celler
WO2006037981A8 (en) Inhibition of tumour cell migration
NZ597489A (en) Methods for treating conditions associated with MASP-2 dependent complement activation
MXPA04012695A (es) Composiciones contra procesos inflamatorios.
WO2005099721A3 (en) Compositions comprising plant-derived polyphenolic compounds and inhibitors of reactive oxygen species and methods of using thereof
WO2009085889A3 (en) Compositions and methods for reducing or preventing water loss from the skin
GEP20053657B (en) Cell Adhesion-Inhibiting Antiinflammatory and Immune-Suppressive Compounds, Pharmaceutical Compositions Thereof
WO2007084162A3 (en) Sirtuin inhibiting compounds
WO2008132021A3 (de) Fungizide mischungen
BR0312063A (pt) Composição nutricional para desintoxicação e prevenção de câncer
WO2008036379A3 (en) Serine hydrolase inhibitors
CA2558429A1 (en) Compositions and methods for preventing or treating an inflammatory response
WO2007041614A3 (en) Long acting vegf inhibitors and methods of use
WO2007015841A3 (en) A method for treating preeclampsia
WO2008025830A3 (en) Pharmaceutical and sunscreen compositions comprising caspase-14
WO2006124477A3 (en) Combination therapy with inhibitors of hmgb and caspase for the treatment of inflammatory diseases
WO2008051793A3 (en) Method of preventing or treating metabolic syndrome
WO2007084542A3 (en) Treatment of inflammatory disorders with triazole compounds
CA2866819C (en) Method for treating inflammation
EP1909804A4 (en) Glucosamine and derivatives thereof as TG inhibitors
WO2007008652A3 (en) Methods and compositions directed to dj-1 as regulator of the anti-oxidant transcription factor nrf2

Legal Events

Date Code Title Description
FG Grant or registration